Yazji Salim

CIK 00018644861 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001864486

Recent Transactions

22 trades

Award
Oncternal Therapeutics, Inc.
Stock Option
2024-02-14+14,200→ 14,200 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2024-01-03$0.50/sh−19,742→ 128,635 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+55,000→ 55,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+70,600→ 70,600 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+354,400→ 354,400 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−354,400→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+92,075→ 92,075 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+210,000→ 210,000 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−92,075→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−55,000→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−210,000→ 0 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-07-03$0.36/sh−16,299→ 148,377 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-14$0.30/sh+5,000→ 164,676 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-13$0.28/sh+10,000→ 159,676 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-12$0.28/sh+10,000→ 149,676 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-02-21+210,000→ 210,000 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-01-03$1.02/sh−9,961→ 139,676 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2022-07-28+82,500→ 149,637 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2022-07-28+55,000→ 55,000 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-01-27$1.69/sh+10,000→ 67,137 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2022-01-20+92,075→ 92,075 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2022-01-03+57,137→ 57,137 total

Companies

Oncternal Therapeutics, Inc.
Chief Medical Officer

Recent Filings

Address

12230 EL CAMINO REAL, SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov